An Jinho, Lee Heetae, Lee Sungwon, Song Youngcheon, Kim Jiyeon, Park Il Ho, Kong Hyunseok, Kim Kyungjae
College of Pharmacy, Sahmyook University, Seoul 01795, Korea.
Climacteric Natural Products Research Institute, Sahmyook University, Seoul 01795, Korea.
Immune Netw. 2021 Mar 25;21(2):e15. doi: 10.4110/in.2021.21.e15. eCollection 2021 Apr.
Abnormal inflammatory responses are closely associated with intestinal microbial dysbiosis. Oral administration of Qmatrix-diabetes-mellitus complex (QDMC), an Aloe gel-based formula, has been reported to improve inflammation in type 2 diabetic mice; however, the role of the gut microbiota in ameliorating efficacy of QDMC remains unclear. We investigated the effect of QDMC on the gut microbiota in a type 2 diabetic aged mouse model that was administered a high-fat diet. Proinflammatory (TNF-α and IL-6) and anti-inflammatory (IL-4 and IL-10) cytokine levels in the fat were normalized via oral administration of QDMC, and relative abundances of , , , and were simultaneously significantly increased. The abundance of these bacteria was correlated to the expression levels of cytokines. Our findings suggest that the immunomodulatory activity of QDMC is partly mediated by the altered gut microbiota composition.
异常的炎症反应与肠道微生物群失调密切相关。据报道,口服基于芦荟凝胶配方的Qmatrix-糖尿病复合物(QDMC)可改善2型糖尿病小鼠的炎症;然而,肠道微生物群在改善QDMC疗效中的作用仍不清楚。我们在给予高脂饮食的2型糖尿病老年小鼠模型中研究了QDMC对肠道微生物群的影响。通过口服QDMC,脂肪中的促炎细胞因子(TNF-α和IL-6)和抗炎细胞因子(IL-4和IL-10)水平恢复正常,同时,[此处原文缺失具体细菌名称]的相对丰度显著增加。这些细菌的丰度与细胞因子的表达水平相关。我们的研究结果表明,QDMC的免疫调节活性部分是由肠道微生物群组成的改变介导的。